| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2974227 | Journal des Maladies Vasculaires | 2015 | 9 Pages |
Abstract
This development may lead to improved care for patients with thrombotic manifestations, normal blood cell counts, and a positive JAK2V617F mutation: multidisciplinary management, including regular hematological monitoring, could lead to the introduction of a cytoreductive treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
C. Fourgeaud, W. El Nemer, U. Michon Pasturel, S. Bonhomme, A. Brignier, I. Lazareth, P. Priollet,